Showing results (1-10 of 486) with videos related to
Sort By:
Pageof 49
Hematology/Oncology Clinics of North America|December 3, 2014
Transplants in myelodysplastic syndromesKatrin Wetzko, Uwe PlatzbeckerSeminars in Hematology|October 20, 2012
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromesUwe PlatzbeckerHematology. American Society of Hematology. Education Program|December 10, 2013
Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insightsUwe PlatzbeckerSeminars in Hematology|September 30, 2017
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitorsAnna Mies, Uwe PlatzbeckerBlood Advances|November 13, 2019
Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?Felicitas Thol, Uwe PlatzbeckerBest Practice & Research. Clinical Haematology|February 11, 2014
Allogeneic stem cell transplantation in MDS: how? When?Uwe Platzbecker, Ghulam MuftiDrugs|November 24, 2018
Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?Katja Sockel, Uwe PlatzbeckerCurrent Hematologic Malignancy Reports|October 5, 2013
When to transplant MDS, and what to do when transplant failsKatja Sockel, Uwe PlatzbeckerInternational Journal of Molecular Sciences|August 10, 2019
Setting Fire to ESA and EMA Resistance: New Targeted Treatment Options in Lower Risk Myelodysplastic SyndromesAnne Sophie Kubasch, Uwe PlatzbeckerPageof 49